Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,477,916
-$415,274 QoQ
Shares Held
96,342
-36.1% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#90
of 290 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. DNLI ranks #51 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in DNLI
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,477,916 | 96,342 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,893,190 | 150,687 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,162,771 | 191,567 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,655,504 | 182,886 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,710,445 | 122,262 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,755,590 | 129,135 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,879,897 | 141,310 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,428,047 | 117,681 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,517,412 | 151,482 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,924,332 | 434,909 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $6,909,540 | 321,973 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,730,727 | 229,313 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,334,002 | 248,526 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,920,657 | 256,973 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $7,890,865 | 283,742 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,364,123 | 207,368 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,986,291 | 101,471 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,660,697 | 175,962 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,430,273 | 121,755 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,045,212 | 60,361 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,728,143 | 34,780 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,940,935 | 51,505 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $975,804 | 11,650 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,401,597 | 39,118 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $411,060 | 17,000 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||